The U.S. conjunctivitis treatment landscape is supported by ongoing pharmaceutical innovation and established ophthalmic care networks. Manufacturers are developing formulations focused on tolerability, dosing convenience, and targeted treatment. Increasing attention to appropriate antibiotic use is also influencing treatment practices and product demand.
The Global Conjunctivitis Treatment...
